Matches in SemOpenAlex for { <https://semopenalex.org/work/W2565993325> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2565993325 abstract "Introduction: Interleukin 17 (IL-17), correlating with advanced stage or poor prognosis of cancer patients, appears to contribute to tumor progression. Here we demonstrated the presence of IL-17 receptor A (IL-17RA) on the tumor cells directly promoting tumor growth, angiogenesis and metastasis. Methods: B16F10 and its derived IL-17RA deficient melanoma cells were stimulated with recombinant IL-17 (γmIL-17) or subcutaneously implanted into C57BL/6 mice. Cell proliferation, cell invasion, tumor growth, metastasis and angiogensis were monitored and anti-tumor immunity was also assessed. Results: As compared with those in the control B16F10 cells, the γmIL-17 inducing cell proliferation, migration and invasion were significantly reduced in the derived IL-17RA-deficient cells. The tumor growth and metastasis were also apparently reduced in the mice bearing the IL-17RA deficient tumors. In fact, not ony the expression of MMP2 and MMP9 but also the production of VEGF and HGF were reduced both in vitro and in vivo. Additionally, the increased levels of IFNγ+ and Granzyme B+ immune cells as well as the reduced numbers of Tregs and MDSCs appeared in the mice bearing the IL-17RA deficient tumors, indicating the lack of IL-17 enhancing the CTL activity and other anti-tumor immunity. Conclusion: These findings support the hypothesis that IL-17/IL-17RA signaling directly promotes tumor growth as well as recruits MDSCs and Treg cells, resulting in tumor progression. It suggests IL-17RA on tumors as a potential therapeutic target for cancer therapy. Citation Format: Ya-Shan Chen, Chao-Lin Liu, Hui-Shan Chen, Su-Ting Wu, Chia-Rui Shen. Decreased tumor progression by the knockdown of interleukin 17 receoptor A in the B16F10 melanoma model. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 442. doi:10.1158/1538-7445.AM2015-442" @default.
- W2565993325 created "2017-01-06" @default.
- W2565993325 creator A5005169817 @default.
- W2565993325 creator A5048140571 @default.
- W2565993325 creator A5052667208 @default.
- W2565993325 creator A5055486441 @default.
- W2565993325 creator A5086840931 @default.
- W2565993325 date "2015-08-01" @default.
- W2565993325 modified "2023-09-27" @default.
- W2565993325 title "Abstract 442: Decreased tumor progression by the knockdown of interleukin 17 receoptor A in the B16F10 melanoma model" @default.
- W2565993325 doi "https://doi.org/10.1158/1538-7445.am2015-442" @default.
- W2565993325 hasPublicationYear "2015" @default.
- W2565993325 type Work @default.
- W2565993325 sameAs 2565993325 @default.
- W2565993325 citedByCount "0" @default.
- W2565993325 crossrefType "proceedings-article" @default.
- W2565993325 hasAuthorship W2565993325A5005169817 @default.
- W2565993325 hasAuthorship W2565993325A5048140571 @default.
- W2565993325 hasAuthorship W2565993325A5052667208 @default.
- W2565993325 hasAuthorship W2565993325A5055486441 @default.
- W2565993325 hasAuthorship W2565993325A5086840931 @default.
- W2565993325 hasConcept C121608353 @default.
- W2565993325 hasConcept C126322002 @default.
- W2565993325 hasConcept C203014093 @default.
- W2565993325 hasConcept C2776090121 @default.
- W2565993325 hasConcept C2776107976 @default.
- W2565993325 hasConcept C2777658100 @default.
- W2565993325 hasConcept C2779013556 @default.
- W2565993325 hasConcept C2779256057 @default.
- W2565993325 hasConcept C2780380082 @default.
- W2565993325 hasConcept C2780394083 @default.
- W2565993325 hasConcept C502942594 @default.
- W2565993325 hasConcept C71924100 @default.
- W2565993325 hasConcept C8891405 @default.
- W2565993325 hasConceptScore W2565993325C121608353 @default.
- W2565993325 hasConceptScore W2565993325C126322002 @default.
- W2565993325 hasConceptScore W2565993325C203014093 @default.
- W2565993325 hasConceptScore W2565993325C2776090121 @default.
- W2565993325 hasConceptScore W2565993325C2776107976 @default.
- W2565993325 hasConceptScore W2565993325C2777658100 @default.
- W2565993325 hasConceptScore W2565993325C2779013556 @default.
- W2565993325 hasConceptScore W2565993325C2779256057 @default.
- W2565993325 hasConceptScore W2565993325C2780380082 @default.
- W2565993325 hasConceptScore W2565993325C2780394083 @default.
- W2565993325 hasConceptScore W2565993325C502942594 @default.
- W2565993325 hasConceptScore W2565993325C71924100 @default.
- W2565993325 hasConceptScore W2565993325C8891405 @default.
- W2565993325 hasLocation W25659933251 @default.
- W2565993325 hasOpenAccess W2565993325 @default.
- W2565993325 hasPrimaryLocation W25659933251 @default.
- W2565993325 hasRelatedWork W1980869461 @default.
- W2565993325 hasRelatedWork W2007827169 @default.
- W2565993325 hasRelatedWork W2063259891 @default.
- W2565993325 hasRelatedWork W2075272822 @default.
- W2565993325 hasRelatedWork W2130667210 @default.
- W2565993325 hasRelatedWork W2136757803 @default.
- W2565993325 hasRelatedWork W2338496302 @default.
- W2565993325 hasRelatedWork W2500884717 @default.
- W2565993325 hasRelatedWork W2810193402 @default.
- W2565993325 hasRelatedWork W2886329196 @default.
- W2565993325 hasRelatedWork W2896584497 @default.
- W2565993325 hasRelatedWork W2911281553 @default.
- W2565993325 hasRelatedWork W2964909259 @default.
- W2565993325 hasRelatedWork W2977186857 @default.
- W2565993325 hasRelatedWork W3012675442 @default.
- W2565993325 hasRelatedWork W3042157197 @default.
- W2565993325 hasRelatedWork W3199588585 @default.
- W2565993325 hasRelatedWork W3204568403 @default.
- W2565993325 hasRelatedWork W342471616 @default.
- W2565993325 hasRelatedWork W3030958949 @default.
- W2565993325 isParatext "false" @default.
- W2565993325 isRetracted "false" @default.
- W2565993325 magId "2565993325" @default.
- W2565993325 workType "article" @default.